enzalutamide,talazoparib
astellas,pfizer
['talapro,2', 'pcsm', 'gucsm', 'talazo', 'enzalu', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'crpc', 'enzalutamide', 'talapro-2']
#asco23: talapro-2: talazoparib + enzalutamide in the first-line setting significantly reduces the risk of progression or death by 55% among pts w/ hrr deficient #mcrpc: #ascodailynews #gucsm #pcsm 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.